Organogenesis Holdings Inc. ORGO 深 滬
等待開盤 08-29 09:30:00 美东时间
5.12
+0.280
+5.79%
華盛通- 最 高5.145
- 今 開4.90
- 成交量 48.62万股
- 最 低 4.90
- 昨 收 4.84
- 總市值 6.50亿
- 52周最高 6.71
- 市盈率 靜 787.69
- 換手率 0.38%
- 52周最低 2.47
- 委 比 -95.84%
- 總股本 1.27亿
- 歷史最高 310.90
- 量 比 0.68
- 振 幅 5.06%
- 歷史最低 1.795
- 每 手 1
- 風險率 0.81%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Organogenesis Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results.
Organogenesis Holdings shares are trading lower after the company reported wors...
08-08 05:01
Organogenesis Holdings Narrows FY2025 Sales Guidance from $480.00M-$535.00M to $480.00M-$510.00M vs $477.80M Est
Organogenesis Holdings (NASDAQ:ORGO) narrows FY2025 sales outlook from $480.00 million-$535.00 million to $480.00 million-$510.00 million vs $477.80 million estimate.
08-08 04:28
Earnings Scheduled For August 7, 2025
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Cantor Fitzgerald Reiterates Overweight on Organogenesis Holdings, Maintains $7 Price Target
Cantor Fitzgerald analyst Ross Osborn reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Overweight and maintains $7 price target.
07-15 20:46
Organogenesis Holdings Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
07-15 20:45
Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation
Organogenesis Holdings Inc. applauds CMS's proposed payment approach for skin substitutes/CTPs under the CY 2026 Physician Fee Schedule, which adopts a per-square-centimeter methodology based on FDA classification. The company believes this structure will reduce abuse, control Medicare spending, and ensure consistent payments across care settings. It also highlights CMS's recognition of PMA products' clinical value, expanding access to innovative...
07-15 13:00
CMS proposed payment rule aims to cut waste, boost chronic disease management
A proposed payment rule unveiled Monday by CMS aims to reduce unnecessary spending and boost quality measures, as well as launch a new payment model centered on chronic disease management. "This rule ...
07-15 05:24
Warner Bros. Discovery, Metsera, eToro Group And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 150 points on M...
06-09 22:56
What to Expect from Altimmune's Earnings
Altimmune (NASDAQ:ALT) will release its quarterly earnings report on Tuesday, 2...
05-13 05:01
